This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
Taking time off is nice, but returning for a July 4-shortened workweek is a bit discombobulating. Speaking of which, I’m landing in your inbox a day early because of the holiday. I hope you eat many hot dogs and watch amazing fireworks. Happy Birthday, America!
Let’s recap a wild week for Cassava Sciences
On Friday, the Justice Department charged the company’s chief scientific collaborator and paid consultant, Hoau-Yan Wang, with multiple counts of fraud. According to the indictment, Wang, a professor at City University of New York, fabricated and falsified data pertaining to Cassava’s drug for Alzheimer’s disease, called simufilam, in order to obtain $16 million in grants from the National Institutes of Health for himself and Cassava.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.